Brinzolamide

Revision as of 19:01, 27 September 2011 by WikiBot (talk | contribs) (Protected "Brinzolamide": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Brinzolamide
File:Brinzolamide.svg
Clinical data
[[Regulation of therapeutic goods |Template:Engvar data]]
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Ophthalmic
ATC code
Legal status
Legal status
Pharmacokinetic data
Protein binding~60%
Elimination half-life111 days
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC12H21N3O5S3
Molar mass383.51 g/mol

Brinzolamide is a carbonic anhydrase inhibitor.

References

  • Ermis S, Ozturk F, Inan U (2005). "Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification". Eye. 19 (3): 303–7. PMID 15258611.
  • Iester M, Altieri M, Michelson G, Vittone P, Traverso C, Calabria G. "Retinal peripapillary blood flow before and after topical brinzolamide". Ophthalmologica. 218 (6): 390–6. PMID 15564757.
  • Kaup M, Plange N, Niegel M, Remky A, Arend O (2004). "Effects of brinzolamide on ocular haemodynamics in healthy volunteers". Br J Ophthalmol. 88 (2): 257–62. PMID 14736787.

Template:Antiglaucoma preparations and miotics


Template:Pharma-stub